Transcatheter Aortic Valve Replacement

Cardiovascular
1
Pipeline Programs
2
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Bayer
BayerLEVERKUSEN, Germany
1 program
1
RivaroxabanPhase 3
LB
Lepu BiopharmaChina - Shanghai
1 program
SinocrownTM Transcatheter Aortic Valve Replacement SystemN/A1 trial
Active Trials
NCT05202977Enrolling By InvitationEst. Aug 2026

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Lepu BiopharmaSinocrownTM Transcatheter Aortic Valve Replacement System

Clinical Trials (1)

NCT05202977Lepu BiopharmaSinocrownTM Transcatheter Aortic Valve Replacement System

Safety and Efficacy of SinocrownTM Transcatheter Aortic Valve Replacement System

Start: Apr 2021Est. completion: Aug 2026
N/AEnrolling By Invitation

Related Jobs in Cardiovascular

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 late-stage (Phase 3) programs — potential near-term approvals
2 companies competing in this space